ArticleIrish journal of medical science2025
Lipoprotein(a) levels in Irish subjects from a specialised lipid centre.
Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLipoprotein(a) is a low-density lipoprotein-like particle covalently bound to apolipoprotein(a). It exhibits pro-atherogenic and pro-inflammatory effects and is an established independent monogenic determinant of atherosclerotic cardiovascular disease and aortic valve stenosis [1-4].
aimsTo establish the Lp(a) distribution in a native Irish population and to explore if a certain lipid profile was associated with high Lp(a) level.
methodsWe retrospectively included all subjects with Lp(a) results tested in our laboratory between January 2021 and December 2022. Patients were divided into Irish and non-Irish name subgroups [16]. We analysed the Lp(a) distribution across lipidaemic subgroups. Statistical analyses were completed in Jamovi programme V2.3.26.
resultsIn total 2762 patients of which 1899 had also a lipid profile. Eighty-five percent (n = 2359) of individuals had Irish surnames and 60% (n = 1419) were males. Mean age of all patients was 56 ± 17 years. The median lipoprotein(a) level was 34.5 nmol/L (interquartile interval < 20 to 153). The Lp(a) median in females was 37.3 (interquartile interval < 20 to 169) versus males 32.9 (interquartile interval < 20 to 147) (p = 0.029). A total of 62.9% (n = 1738) of Irish subjects had Lp(a) levels < 75 nmol/L, 7.56% of them (n = 209) between 75 and 125 nmol/L and 29.5% (n = 815) of subjects had Lp(a) > 125 nmol/L.
conclusionsThis is the largest study of Lp(a) distribution in an Irish population revealing positively skewed Lp(a) serum levels. This is not entirely reflective of the general population but brings to the fore the additional hidden high risks in those patients attending cardiovascular services. More education is needed to increase the use of Lp(a) measurements and guide further therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.